Borate, Uma <br/><br/>
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.  [electronic resource] 

 -  Leukemia research  May 2016 
 - 25-31 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2016.02.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brentuximab Vedotin<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunoenzyme Techniques<br/>Ki-1 Antigen--metabolism<br/>Male<br/>Mastocytosis, Systemic--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis